1. Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Issue 7 (2nd July 2016) Authors: Sunakawa, Yu; Yang, Dongyun; Moran, Miriana; Astrow, Stephanie H.; Tsuji, Akihito; Stephens, Craig; Zhang, Wu; Cao, Shu; Takahashi, Takehiro; Denda, Tadamichi; Shimada, Ken; Kochi, Mitsugu; Nakamura, Masato; Kotaka, Masahito; Segawa, Yoshihiko; Masuishi, Toshiki; Takeuchi, Masahiro; Fujii, Masash... Journal: Cancer biology & therapy Issue: Volume 17:Issue 7(2016) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan. Issue 1 (December 2016) Authors: Takata, Kosuke; Fujita, Ken-ichi; Kubota, Yutaro; Ishida, Hiroo; Ichikawa, Wataru; Shimada, Ken; Sekikawa, Takashi; Taki-Takemoto, Iori; Kamei, Daisuke; Iwai, Shinichi; Sasaki, Yasutsuna Journal: Journal of pharmaceutical health care and sciences Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crizotinib-induced pancreatic pseudocyst: a novel adverse event. (8th September 2015) Authors: Ishida, Hiroo; Ichikawa, Wataru; Sasaki, Yasutsuna Journal: BMJ case reports Issue: Volume 2015 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does a higher response rate to systemic chemotherapy result in a higher resection rate in patients with initially unresectable colorectal liver metastases?. (June 2013) Authors: Sunakawa, Yu; Ichikawa, Wataru; Takahashi, Takehiro; Shimada, Ken; Sasaki, Yasutsuna Journal: Acta oncologica Issue: Volume 52:Number 5(2013) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Higher Systemic Exposure to Unbound Active Metabolites of Regorafenib Is Associated With Short Progression‐Free Survival in Colorectal Cancer Patients. Issue 3 (10th March 2020) Authors: Kubota, Yutaro; Fujita, Ken‐ichi; Takahashi, Takehiro; Sunakawa, Yu; Ishida, Hiroo; Hamada, Kazuyuki; Ichikawa, Wataru; Tsunoda, Takuya; Shimada, Kazuhiro; Masuo, Yusuke; Kato, Yukio; Sasaki, Yasutsuna Journal: Clinical pharmacology & therapeutics Issue: Volume 108:Issue 3(2020) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?. Issue 8 (August 2015) Authors: Sasaki, Yasutsuna; Hamada, Kazuyuki; Kaneta, Toshikado; Takahashi, Takehiro; Kubota, Yutaro; Ishida, Hiroo; Ichikawa, Wataru Journal: Cancer science Issue: Volume 106:Issue 8(2015:Aug.) Page Start: 1100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel laser melting stir process for microwelding. (August 2020) Authors: Sakai, Yasunori; Ichikawa, Wataru; Tanaka, Tomohisa Journal: Manufacturing letters Issue: Volume 25(2020) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Predictive value of TLR7 polymorphism for cetuximab‐based chemotherapy in patients with metastatic colorectal cancer. Issue 6 (21st June 2017) Authors: Okazaki, Satoshi; Stintzing, Sebastian; Sunakawa, Yu; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; West, Jordan D.; Gopez, Roel; Akihito, Tsuji; Ichikawa, Wataru; Heinemann, Volker; DePaolo, R. William;... Journal: International journal of cancer Issue: Volume 141:Issue 6(2017:Sep. 15) Page Start: 1222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial. (May 2023) Authors: Kawakami, Hisato; Sunakawa, Yu; Inoue, Eisuke; Matoba, Ryo; Noda, Kenta; Sato, Toshiyuki; Suminaka, Chihiro; Yamaki, Mami; Sakamoto, Yasuhiro; Kawabata, Ryohei; Ishiguro, Atsushi; Akamaru, Yusuke; Kito, Yosuke; Yabusaki, Hiroshi; Matsuyama, Jin; Takahashi, Masazumi; Makiyama, Akitaka; Hayashi, Hi... Journal: European journal of cancer Issue: Volume 184(2023) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗